Aster DM Healthcare is strengthening its presence in Bengaluru with a fresh investment aimed at expanding capacity and improving specialized care.
AI in healthcare is moving from promise to practice as multiple states in India roll out new tech-driven initiatives to improve diagnosis, training, and patient care. In Madhya Pradesh, the state government has launched a pilot program across 10...
The Indian government has outlined a clear strategy to transform the country’s pharmaceutical sector from being the “Pharmacy of the World” — known for affordable generics — to a global leader in high-value innovations, especially biologic...
India’s INR 10,000 crore startup fund boosts health tech and medtech startups, giving a strong push to innovation in critical healthcare areas. Announced as part of the government’s renewed funding strategy, the initiative is designed to channel...
Weight-loss injections are gaining popularity across India, often positioned as a simple and effective solution for obesity. But only 4 in 10 Indians See Big Weight-Loss Results. A study conducted at Max Super Speciality Hospital, involving 150...
In a major boost to robotic cardiac surgery, Apollo Hospitals, Jubilee Hills, has completed 100 assisted robotic cardiac surgeries in just 155 days using the da Vinci Surgical System. The achievement highlights how fast advanced, minimally...
AstraZeneca Pharma has secured a key Calquence approval in India, receiving clearance from the Central Drugs Standard Control Organisation to import and distribute Acalabrutinib tablets 100 mg under the brand name Calquence.
India has taken an important step to bring more clarity and consistency to its medical devices sector by introducing a standardised testing fee framework. The move is expected to make the system more transparent, predictable, and affordabl...
The Centre is considering using the extensive India Post network to expand the reach of Jan Aushadhi Kendras and enable doorstep delivery of medicines. The move is aimed at improving access to affordable medicines in India, especially in rura...
CuraTeQ Biologics, a subsidiary of Aurobindo Pharma, has reported encouraging results from its Phase 3 clinical trial of BP11 biosimilar, a biosimilar to the widely used biologic drug Xolair (omalizumab). The announcement marks a key milesto...
.jpg)
.jpg)
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")